STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 251 participants.

Also called NCT03777631

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 251 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03777631
Other papers using this trial's data
  • Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial JAMA neurology, 2026-04-01 DOI, PubMed 41770549, PMC12954600 PubMed links an erratum for this paper. Erratum: PMID 41973432 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03777631. Randomized; no masking; primary purpose prevention. Start 2018-04-01 (actual); primary completion 2026-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study
Acronym
STABLED
Condition
Atrial Fibrillation Non-Rheumatic
Intervention (Procedure)
Catheter ablation
Lead sponsor
Nippon Medical School (class: other)
Collaborator
Daiichi Sankyo Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03777631
Content hash
187097141d63743d1f259a1bf056eea0de39616564665fa4acd02edf19f60eb0